GIPR Antibody Blocking peptide
GIPR Antibody Blocking peptide
Product Specifications
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of human GIPR. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1054502-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O6 Lysophospholipase L2 (pldB)
Sign In for Pricing
View Details MBS1054502-02 0.02 mg (Yeast)
Recombinant Escherichia coli O6 Lysophospholipase L2 (pldB)
Sign In for Pricing
View Details MBS1054502-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O6 Lysophospholipase L2 (pldB)
Sign In for Pricing
View Details MBS1054502-04 0.1 mg (Yeast)
Recombinant Escherichia coli O6 Lysophospholipase L2 (pldB)
Sign In for Pricing
View Details MBS1054502-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O6 Lysophospholipase L2 (pldB)
Sign In for Pricing
View Details